[Transfusion in autologous and allogenic hematopoietic stem cell transplant: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Autor: Giraud C; CHU de Poitiers, service d'hématologie et de thérapie cellulaire, 2, rue de la Miletrie, 86021 Poitiers, France; Laboratoire de thérapie cellulaire EFS Nouvelle-Aquitaine, 350, avenue Jacques-Cœur, BP 482, 86012 Poitiers cedex, France. Electronic address: christine.giraud@chu-poitiers.fr., Thibert JB; Laboratoire de thérapie cellulaire EFS Bretagne, 3, rue Pierre-Jean Gineste, 35016 Rennes, France., Desbrosses Y; CHRU Jean-Minjoz, service d'hématologie, unité de soins intensifs, 3, boulevard Fleming, 25030 Besançon cedex, France., Debiol B; EFS siège, 20, avenue du stade de France, 93218 La Plaine Saint-Denis, France., Alsuliman T; CH de Boulogne-sur-Mer, allée Jacques-Monod, 62321 Boulogne-sur-Mer, France; CHRU de Lille, service des maladies du sang, 2, avenue Oscar-Lambret, 59037 Lille, France., Bardiaux L; Laboratoire immuno-hématologie EFS Toulouse-Purpan, avenue de Grande-Bretagne, BP 3210, 31027 Toulouse cedex, France., Garban F; CHU de Grenoble-Alpes, clinique d'hématologie, avenue Maquis du Grésivaudan, 38700 La Tronche, France., Huynh TNP; Institut Jules-Bordet, service d'hématologie, 1, rue Héger-Bordet, 1000 Bruxelles, Belgique., Samsonova O; Groupement hospitalier Lyon Sud, transfusion hôpital de jour hématologie, 165, chemin du Grand-Revoyet, 69310 Pierre-Bénite, France., Yakoub-Agha I; CHU de Lille, maladies du sang, unité d'allogreffe de CSH, 59000 Lille, France; Université de Lille 2, LIRIC, Inserm U995, 59000 Lille, France., Bruno B; Hôpital Jeanne de Flandre, CHRU de Lille, hématologie pédiatrique, unité de greffe, avenue Eugène-Avinée, 59037 Lille cedex, France.

Publikováno v: Bulletin du cancer [Bull Cancer] 2019 Jan; Vol. 106 (1S), pp. S52-S58. Date of Electronic Publication: 2019 Jan 18.

Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy.

Autor: Comont T; Service de Médecine Interne, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France; Université Toulouse III Paul Sabatier, Toulouse, France., Tavitian S; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France., Bardiaux L; Etablissement Français du Sang Pyrénées-Méditerranée, Toulouse, France., Fort M; Laboratoire d'Immunologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France., Debiol B; Etablissement Français du Sang Pyrénées-Méditerranée, Toulouse, France., Morère D; Etablissement Français du Sang Pyrénées-Méditerranée, Toulouse, France., Bérard E; Service d'Epidémiologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; UMR 1027, INSERM-Université de Toulouse III, Toulouse, France., Delabesse E; Université Toulouse III Paul Sabatier, Toulouse, France; Laboratoire d'Hématologie Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France; Centre de Recherches en Cancérologie de Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France., Luquet I; Université Toulouse III Paul Sabatier, Toulouse, France; Laboratoire d'Hématologie Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France; Centre de Recherches en Cancérologie de Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France., Martinez S; Unité d'hémovigilance, Centre Hospitalier Universitaire de Toulouse, Toulouse, France., Huguet F; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France., Récher C; Université Toulouse III Paul Sabatier, Toulouse, France; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France; Centre de Recherches en Cancérologie de Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France. Electronic address: recher.christian@iuct-oncopole.fr., Bertoli S; Université Toulouse III Paul Sabatier, Toulouse, France; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France; Centre de Recherches en Cancérologie de Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France.

Publikováno v: Leukemia research [Leuk Res] 2017 Oct; Vol. 61, pp. 62-67. Date of Electronic Publication: 2017 Aug 30.

Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 Cases.

Autor: Rostaing L; CHU Rangueil, Nephrology, Dialysis, Transplantation, Toulouse, France. rostaing.l@chu-toulouse.fr.; CHU Purpan, INSERM01043, IFR-BMT, Toulouse, France. rostaing.l@chu-toulouse.fr.; Université Toulouse 3 Paul Sabaiter, Toulouse, France. rostaing.l@chu-toulouse.fr., Karam B; CHU Rangueil, DNTO, Toulouse, France., Congy-Jolivet N; Université Toulouse 3 Paul Sabaiter, Toulouse, France.; CHU Rangueil, Laboratory of Immunology, Toulouse, France., Hage V; CHU Rangueil, Nephrology, Dialysis, Transplantation, Toulouse, France., Sallusto F; CHU Rangueil, Department of Urology, Andrology and Transplantation, Toulouse, France., Esposito L; CHU Rangueil, Nephrology, Dialysis, Transplantation, Toulouse, France., Doumerc N; CHU Rangueil, Department of Urology, Andrology and Transplantation, Toulouse, France., Debiol B; CHU Purpan, Etablissement Français du Sang de Midi-Pyrénées, Toulouse, France., Guilbeau-Frugier C; CHU Rangueil, Laboratory of Histopathology, Toulouse, France., Game X; Université Toulouse 3 Paul Sabaiter, Toulouse, France.; CHU Rangueil, Department of Urology, Andrology and Transplantation, Toulouse, France., Allal A; CHU Rangueil, Nephrology, Dialysis, Transplantation, Toulouse, France., Kamar N; CHU Rangueil, Nephrology, Dialysis, Transplantation, Toulouse, France.; Université Toulouse 3 Paul Sabaiter, Toulouse, France.; IFB-BMT - CHU Purpan, INSERM U563, Toulouse, France.

Publikováno v: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy [Ther Apher Dial] 2016 Oct; Vol. 20 (5), pp. 507-516. Date of Electronic Publication: 2016 Apr 13.

Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.

Autor: Belliere J; Department of Nephrology and Organ Transplantation, University Hospital, Toulouse, France., Kamar N; Department of Nephrology and Organ Transplantation, University Hospital, Toulouse, France.; INSERM U563, IFR-BMT, CHU Purpan, Toulouse, France.; University Paul Sabatier, Toulouse, France., Mengelle C; INSERM U563, IFR-BMT, CHU Purpan, Toulouse, France.; Department of Virology, CHU Purpan, Toulouse, France., Allal A; Department of Nephrology and Organ Transplantation, University Hospital, Toulouse, France., Sallusto F; Department of Urology and Kidney Transplantation, CHU Rangueil, Toulouse, France., Doumerc N; Department of Urology and Kidney Transplantation, CHU Rangueil, Toulouse, France., Game X; Department of Urology and Kidney Transplantation, CHU Rangueil, Toulouse, France., Congy-Jolivet N; University Paul Sabatier, Toulouse, France.; Laboratory of Immunology, CHU Rangueil, Toulouse, France., Esposito L; Department of Nephrology and Organ Transplantation, University Hospital, Toulouse, France., Debiol B; Etablissement Français du Sang, CHU Purpan, Toulouse, France., Rostaing L; Department of Nephrology and Organ Transplantation, University Hospital, Toulouse, France.; INSERM U563, IFR-BMT, CHU Purpan, Toulouse, France.; University Paul Sabatier, Toulouse, France.

Publikováno v: Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2016 Mar; Vol. 29 (3), pp. 315-22. Date of Electronic Publication: 2015 Dec 16.

Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages.

Autor: van Osch, Thijs L. J.^1,2, Steuten, Juulke³, Nouta, Jan⁴, Koeleman, Carolien A. M.⁴, Bentlage, Arthur E. H.^1,2, Heidt, Sebastiaan⁵, Mulder, Arend⁵, Voorberg, Jan⁶, van Ham, S. Marieke^3,7, Wuhrer, Manfred⁴, Brinke, Anja ten³ A.tenbrinke@sanquin.nl, Vidarsson, Gestur^1,2 G.vidarsson@sanquin.nl

Publikováno v: Platelets. Dec2023, Vol. 34 Issue 1, p11-19. 9p.